The case for conservative management of early HIV disease

[1] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969

[2] CARR A, 1998, 5 C RETR OPP INF FEB

[3] *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P889

[4] Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 : S121 - S130

[5] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J]. NATURE, 1995, 374 (6522) : 569 - 571

[6] CONDRA JH, 1996, 11 INT C AIDS JUL 7

[7] HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J]. NATURE MEDICINE, 1997, 3 (05) : 533 - 540

[8] HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22): : 3273 - 3277

[9] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862

[10] HEPATOMEGALY WITH SEVERE STEATOSIS IN HIV-SEROPOSITIVE PATIENTS [J]. AIDS, 1993, 7 (03) : 379 - 385

[1] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969

[2] CARR A, 1998, 5 C RETR OPP INF FEB

[3] *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P889

[4] Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 : S121 - S130

[5] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J]. NATURE, 1995, 374 (6522) : 569 - 571

[6] CONDRA JH, 1996, 11 INT C AIDS JUL 7

[7] HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J]. NATURE MEDICINE, 1997, 3 (05) : 533 - 540

[8] HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22): : 3273 - 3277

[9] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862

[10] HEPATOMEGALY WITH SEVERE STEATOSIS IN HIV-SEROPOSITIVE PATIENTS [J]. AIDS, 1993, 7 (03) : 379 - 385